In the BioHarmony Drug Report Database

"Preview" Icon

Imiquimod

Aldara, Zyclara (imiquimod) is a small molecule pharmaceutical. Imiquimod was first approved as Aldara on 1997-02-27. It is used to treat actinic keratosis, basal cell carcinoma, and condylomata acuminata in the USA. It has been approved in Europe to treat actinic keratosis, basal cell carcinoma, condylomata acuminata, and keratosis. It is known to target toll-like receptor 7. Aldara’s patents are valid until 2030-04-30 (FDA).

 

Trade Name

 

Aldara, Zyclara
 

Common Name

 

imiquimod
 

ChEMBL ID

 

CHEMBL1282
 

Indication

 

actinic keratosis, basal cell carcinoma, condylomata acuminata, keratosis
 

Drug Class

 

Immunomodulators

Image (chem structure or protein)

Imiquimod structure rendering